Crossmark

The potassium channel KCa3.1 represents a valid pharmacological target for microgliosis-induced neuronal impairment in a mouse model of Parkinson’s disease

Crossref DOI link: https://doi.org/10.1186/s12974-019-1682-2

Published Online: 2019-12-26

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lu, Jia

Dou, Fangfang

Yu, Zhihua
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81773699)
License Information

Text and Data Mining valid from 2019-12-01

Version of Record valid from 2019-12-26
More Information

Article History

Received: 25 August 2019

Accepted: 17 December 2019

First Online: 26 December 2019

Ethics approval and consent to participate

: The study (ethics protocol number: A-2015-010) was approved by the Animal Care and Use Committee of the Shanghai Jiao Tong University School of Medicine, Shanghai, China.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below